Huons Co. Ltd

243070 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

15,700.00KRW-190.00 (-1.20%)

Price History

Full chart

Market Stats

Previous Close15,890.00

Open15,870.00

Day Range15,610.00 – 15,970.00

52-Week Range18,800.00 – 40,878.47

Volume32.28K

Market Cap225.35B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield6.06%

Beta0.22

50-Day Avg22,843.00

200-Day Avg26,506.00

About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices. The company was formerly known as Kwang Myung Pharm and changed its name to Huons Co., Ltd. in June 2003. Huons Co., Ltd. was founded in 1965 and is headquartered in Seongnam-si, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. SuYeong Song
Employees0
HeadquartersHuonsGlobal Bldg, Seongnam-si, South Korea, Korea
Websitehttps://www.huons.com

Leadership

Mr. SuYeong SongCEO & Representative Director · b. 1963
Mr. SinWon KangChief Financial Officer · b. 1972
Jung-hun KimChief Disclosure Officer
Mr. Heonwook ParkManaging Director of Marketing · b. 1977
Mr. Hosoon ChungManaging Director of Marketing · b. 1971
Mr. Jungsik KimManaging Director of Sales · b. 1973
Mr. JinSuk LeeManaging Director · b. 1971
Ms. JiYoung YangManaging Director of Research & Development · b. 1979
Mr. SiBaek KimMD & Inside Director · b. 1966
Mr. YoHeon EomManaging Director of Overseas Business Division · b. 1975

Financials

Income Statement

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	168.97B	284.84B	328.60B	365.02B	406.68B	436.91B	492.39B	552.01B	590.23B	620.77B
Growth (%)	-	+68.58%	+15.36%	+11.08%	+11.41%	+7.43%	+12.70%	+12.11%	+6.92%	+5.17%
Cost of Revenue	79.68B	128.99B	147.04B	165.02B	186.82B	188.05B	224.39B	265.90B	305.01B	338.55B
Gross Profit	89.28B	155.85B	181.55B	199.99B	219.85B	248.86B	268.00B	286.11B	285.22B	282.21B
Gross Margin	52.84%	54.72%	55.25%	54.79%	54.06%	56.96%	54.43%	51.83%	48.32%	45.46%
Operating Expense	69.95B	119.63B	133.21B	151.93B	165.73B	203.58B	230.10B	230.11B	249.53B	236.61B
Operating Income	19.33B	36.22B	48.34B	48.06B	54.12B	45.28B	37.89B	56.00B	35.69B	45.60B
Operating Margin	11.44%	12.72%	14.71%	13.17%	13.31%	10.36%	7.70%	10.15%	6.05%	7.35%
EBITDA	-	-	-	-	-	-	60.15B	83.84B	62.20B	81.97B
EBITDA Margin	-	-	-	-	-	-	12.22%	15.19%	10.54%	13.21%
Net Income	15.33B	35.07B	45.23B	38.21B	55.58B	30.75B	22.44B	50.47B	29.45B	42.66B
Net Income Margin	9.07%	12.31%	13.77%	10.47%	13.67%	7.04%	4.56%	9.14%	4.99%	6.87%
R&D	21.30B	19.86B	20.69B	25.29B	26.54B	30.90B	36.47B	32.88B	34.87B	41.80B
R&D as % of Total Revenue	12.61%	6.97%	6.30%	6.93%	6.53%	7.07%	7.41%	5.96%	5.91%	6.73%
Interest Expense	0	0	0	0	1.80B	2.69B	3.16B	2.50B	3.23B	6.25B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.44%	0.61%	0.64%	0.45%	0.55%	1.01%

Balance Sheet

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	179.34B	216.00B	251.37B	300.34B	416.50B	436.90B	472.63B	537.29B	606.29B	680.28B
Total Liabilities	85.47B	93.31B	88.10B	105.83B	177.70B	170.80B	190.17B	206.87B	260.31B	265.42B
Total Equity	93.88B	122.69B	163.27B	194.52B	238.80B	266.09B	282.46B	325.40B	345.97B	373.91B
Cash	15.98B	39.44B	25.95B	37.82B	26.93B	57.28B	30.70B	64.70B	54.17B	56.07B
Total Debt	32.79B	35.49B	19.88B	32.61B	99.63B	-	-	-	-	-
Net Debt	-	-	-	-	67.10B	8.18B	65.56B	50.68B	120.31B	119.35B

Cash Flow

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	43.38B	30.21B	20.88B	42.12B	46.51B	55.59B	32.02B	52.14B	52.56B	45.01B
Investing Cash Flow	-25.83B	-11.75B	-25.48B	-28.81B	-124.52B	13.99B	-66.71B	3.02B	-107.94B	-
Financing Cash Flow	2.23B	5.12B	-9.11B	-1.61B	67.56B	7.75B	7.75B	-21.08B	43.58B	-
Capital Expenditure	6.10B	8.53B	10.28B	19.26B	37.72B	40.69B	41.32B	44.77B	84.21B	24.32B
Free Cash Flow	-	-	-	28.77B	8.28B	14.46B	-10.69B	7.38B	-31.65B	20.69B
Dividends Paid	3.71B	3.71B	3.71B	6.53B	6.28B	5.87B	6.46B	10.65B	7.47B	12.25B
FCF to OCF	-	-	-	68.31%	17.80%	26.00%	-33.38%	14.15%	-60.22%	45.97%
Dividend Paid to FCF	-	-	-	22.68%	75.86%	40.63%	-60.41%	144.30%	-23.61%	59.21%

Earnings

Report Date	Nov 14, 2016	Mar 31, 2017	May 15, 2017	Aug 13, 2017	Nov 12, 2017	Feb 12, 2018	May 14, 2018	Aug 13, 2018	Nov 11, 2018	Feb 20, 2019	May 14, 2019	Aug 13, 2019	Nov 12, 2019	Mar 11, 2020	May 12, 2020	Aug 12, 2020	Nov 12, 2020	Feb 14, 2021	May 10, 2021	Aug 16, 2021	Nov 14, 2021	Feb 15, 2022	May 15, 2022	Aug 9, 2022	Nov 3, 2022	Feb 13, 2023	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	758.26	589.53	936.98	821.49	1238.02	1150.97	1073.55	1103.15	1058.68	1032.73	848.18	904.55	1383.64	1420.91	1137.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	708.01	308.68	820.31	588.01	1075.07	1057.85	885.67	1085.95	1360.33	1250.41	874.38	733.06	990.08	922.64	880.91	960.91	1192.73	2577.45	811.00	784.00	1273.00	-95.30	716.82	629.00	197.00	319.28	1163.20	1240.00	985.00	843.52	762.00	681.00	580.00	333.69	1025.00	976.00	680.01	930.98	29.00	-21.24
Surprise	-	-	-	-	41.78%	79.44%	-5.48%	32.19%	9.88%	8.64%	-18.55%	-33.55%	-6.48%	-10.66%	3.86%	6.23%	-13.80%	81.39%	-28.67%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	Pre-market	Pre-market	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap225.35B

Enterprise Value362.83B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.37

Price / Book0.60

Revenue (TTM)607.75B

Gross Profit (TTM)262.84B

EBITDA54.84B

Profit Margin3.10%

Operating Margin1.99%

Return on Equity4.33%

Return on Assets2.14%

Shares Outstanding11.65M

Shares Float6.28M

Beta0.22

Dividend Yield6.06%

Dividend Rate1,170.00

Payout Ratio72.28%

Dividends

20263×

200.00Aug 28, 2026200.00May 26, 2026200.00Apr 2, 2026

20254×

570.00Nov 24, 2025150.00Aug 20, 2025300.00Jun 27, 2025330.00Mar 28, 2025

20242×

300.00Jun 27, 2024330.00Mar 29, 2024

20231×

300.00Jun 29, 2023

20221×

600.00Dec 28, 2022

20211×

600.00Dec 29, 2021

20201×

545.45Dec 29, 2020

20191×

578.51Dec 27, 2019

20181×

601.05Dec 27, 2018

20171×

341.51Dec 27, 2017

Stock Splits

Dec 29, 202111:10
Dec 29, 202011:10
Dec 27, 201911:10
Dec 27, 201811:10
May 15, 20186:5
Dec 27, 201711:10
Dec 28, 201621:20